DNA Capital attracts J&J Impact Ventures, BTG, and BNDES to a new healthcare fund of up to R$500 million
Monday, May 11, 2026 · first reported by NeoFeed
DNA Capital launched healthcare fund targeting up to R$500M (~$100M), attracting J&J Impact Ventures, BTG, and BNDES as LPs.
- Firm
- DNA Capital
- Also named
- J&J Impact Ventures, BTG, BNDES
- Size
- $100M
- Stage
- Target
- Asset class
- Venture
- Geography
- Latin America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Venture capital
From the same day- Lumen Ventures and Ulixes SGR Launch €100 Million Venture Capital Fundleadersleague.com
- KKR, HASI-Backed Sustainable Infrastructure Platform CarbonCount Raises Over $500 MillionESG Today
- New manager Kalos raises $78.8m to address aging, other societal challengesVenture Capital Journal
- Mother Ventures Closes $10M Debut Fund Built Around the Mom-as-Consumer MarketFemtech Insider
- Restive Ventures eyes AI-native financial services opportunity with $45m Fund IIIAltAssets
- Fuse launches Fuse Venture Partners III, for undisclosed target sizeVenture Capital Journal